The First Decade of Biologic TNF Antagonists in Clinical Practice: Lessons Learned, Unresolved Issues and Future Directions

Petros P. Sfikakis

Open source

DOI
10.1159/000289205
Published
2010
Container
Current Directions in Autoimmunity
Publisher
KARGER
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000289205,
  title = {The First Decade of Biologic TNF Antagonists in Clinical Practice: Lessons Learned, Unresolved Issues and Future Directions},
  author = {Petros P. Sfikakis},
  year = {2010},
  journal = {Current Directions in Autoimmunity},
  doi = {10.1159/000289205},
  url = {https://doi.org/10.1159/000289205}
}

RIS

TY  - JOUR
TI  - The First Decade of Biologic TNF Antagonists in Clinical Practice: Lessons Learned, Unresolved Issues and Future Directions
AU  - Petros P. Sfikakis
PY  - 2010
JO  - Current Directions in Autoimmunity
DO  - 10.1159/000289205
UR  - https://doi.org/10.1159/000289205
ER  - 

APA

Sfikakis, P. P. (2010). The First Decade of Biologic TNF Antagonists in Clinical Practice: Lessons Learned, Unresolved Issues and Future Directions. Current Directions in Autoimmunity. https://doi.org/10.1159/000289205

Source records